Study reporting increased SLC16A1 mRNA expression level in high-grade gliomas used our anti-SLC16A1 polyclonal antibody


March, 2021 (Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan)

The solute carrier family member 16, 1SLC16A1, positively correlates with high-grade gliomas.


Using our anti-SLC16A1 polyclonal antibody (HPA003324), this study shows that SLC16A1 mRNA expression level is significantly increased in high-grade gliomas in contrast to low-grade gliomas and non-tumor controls.

Read more:

Anti-SLC16A1 antibody: